| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.02 |